Bortezomib Combined Chemotherapy for Children with Relapsed/refractory Acute Lymphoblastic Leukemia

被引：0
|
作者：
Sakaguchi, Hirotoshi [1 ]
Maemura, Ryo [1 ]
Yamamori, Ayako [1 ]
Wakamatsu, Manabu [1 ]
Yoshida, Nao [1 ]
Kato, Koji [1 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O29-3-1
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [21] Outcome of risk adapted therapy for relapsed/refractory acute lymphoblastic leukemia in children
    Belgaumi, Asim F.
    Al-Seraihy, Amal
    Siddiqui, Khawar S.
    Ayas, Mouhab
    Bukhari, Asem
    Al-Musa, Abdulrahman
    Al-Ahmari, Ali
    El-Solh, Hassan
    LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 547 - 554
  • [22] NELARABINE IN CHILDREN WITH REFRACTORY AND RELAPSED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Myakova, N.
    Diakonova, Y.
    Bydanov, O.
    Ponomareva, N.
    Fechina, L.
    Boychenko, E.
    Karachunsky, A.
    Shamardina, A.
    HAEMATOLOGICA, 2015, 100 : 349 - 349
  • [23] A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia
    Burke, Michael J.
    Lamba, Jatinder K.
    Pounds, Stanley
    Cao, Xueyuan
    Ghodke-Puranik, Yogita
    Lindgren, Bruce R.
    Weigel, Brenda J.
    Verneris, Michael R.
    Miller, Jeffrey S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (09) : 889 - 895
  • [24] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
    Aharon Ronson
    Ariella Tvito
    Jacob M. Rowe
    Current Oncology Reports, 2016, 18
  • [25] Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults
    Ronson, Aharon
    Tvito, Ariella
    Rowe, Jacob M.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (06)
  • [26] Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia
    Walker, Alison R.
    Wang, Hongyan
    Walsh, Katherine
    Bhatnagar, Bhavana
    Vasu, Sumithira
    Garzon, Ramiro
    Canning, Renee
    Geyer, Susan
    Wu, Yue-Zhong
    Devine, Steven M.
    Klisovic, Rebecca
    Blum, William
    Marcucci, Guido
    LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2100 - 2108
  • [27] Blinatumomab vs Chemotherapy Among Children With Relapsed Acute Lymphoblastic Leukemia Reply
    Locatelli, Franco
    Zugmaier, Gerhard
    von Stackelberg, Arend
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (04): : 359 - 359
  • [28] Efficacy of bortezomib combined with Hyper-CVAD in adults with relapsed acute lymphoblastic leukemia or positive measurable residual disease; effect of bortezomib in leukemia
    Penafiel, Christian Omar Ramos
    Samano, Daniela Perez
    Rodriguez, Adan German Gallardo
    Palacio, Camila Terreros
    Carrillo, Irma Olarte
    Murillo, Carlos Martinez
    Lampon, Gilberto Barranco
    Garcia, Alvaro Cabrera
    Tovar, Adolfo Martinez
    BLOOD RESEARCH, 2025, 60 (01)
  • [29] A Phase II Trial of Decitabine and Vorinostat in Combination with Chemotherapy for Relapsed/Refractory Acute Lymphoblastic Leukemia
    Burke, Michael J.
    Lamba, Jatinder
    Weigel, Brenda
    Bachanova, Veronika
    Verneris, Michael R.
    Miller, Jeffrey S.
    BLOOD, 2012, 120 (21)
  • [30] Venetoclax Combined with Intensive Chemotherapy: A New Hope for Refractory and/or Relapsed Acute Myeloid Leukemia?
    Rahme, Ramy
    Braun, Thorsten
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
12345